迈普医学
(301033)
| 流通市值：29.99亿 | | | 总市值：35.63亿 |
| 流通股本：5693.51万 | | | 总股本：6763.10万 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 124,308,410.25 | 97,987,547.7 | 107,238,882.98 | 74,017,230.33 |
| 交易性金融资产 | 199,492,606.02 | 184,572,967.4 | 193,998,906.56 | 231,812,485.83 |
| 应收票据及应收账款 | 23,245,337.97 | 27,366,955.45 | 19,727,233.17 | 25,027,134.39 |
| 应收账款 | 23,245,337.97 | 27,366,955.45 | 19,727,233.17 | 25,027,134.39 |
| 预付款项 | 7,705,687.29 | 6,147,240.61 | 7,473,700.29 | 4,899,054.78 |
| 其他应收款合计 | 1,581,274.29 | 1,477,949.01 | 1,618,652.21 | 1,108,003.26 |
| 存货 | 47,692,459.4 | 43,036,603.99 | 45,443,124.18 | 37,064,500.38 |
| 其他流动资产 | 4,183,741.89 | 779,198.02 | 2,750,550.47 | 1,265,774.35 |
| 流动资产合计 | 408,209,517.11 | 361,368,462.18 | 378,251,049.86 | 375,194,183.32 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 7,228,386.09 | 7,259,136.1 | 2,284,798.71 | 2,364,417.94 |
| 其他非流动金融资产 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 |
| 投资性房地产 | 10,834,139.16 | 10,905,375.72 | 10,976,612.28 | 11,047,848.84 |
| 固定资产 | 291,691,349 | 294,775,793.59 | 294,953,357.88 | 299,378,337.74 |
| 在建工程 | 9,052,321.14 | 4,132,420.55 | 985,321.1 | - |
| 使用权资产 | 8,978,562.22 | 8,943,460.1 | 9,174,756.47 | - |
| 无形资产 | 62,705,215.6 | 64,220,741.91 | 66,079,307.85 | 68,094,289.73 |
| 开发支出 | 37,537,444.49 | 36,199,839.88 | 34,872,919.06 | 32,889,491.56 |
| 长期待摊费用 | 843,190.86 | 938,269.06 | 927,838.77 | 1,025,604.21 |
| 递延所得税资产 | 6,504,222.79 | 8,777,715.21 | 9,389,065.62 | 9,827,815.82 |
| 其他非流动资产 | 55,172,921.44 | 45,781,525.07 | 41,932,925.2 | 37,614,574.2 |
| 非流动资产合计 | 548,547,752.79 | 539,934,277.19 | 529,576,902.94 | 520,242,380.04 |
| 资产总计 | 956,757,269.9 | 901,302,739.37 | 907,827,952.8 | 895,436,563.36 |
| 流动负债: | | | | |
| 衍生金融负债 | 95,848.26 | 78,527.03 | 64,103.77 | 153,298.98 |
| 应付票据及应付账款 | 18,329,950.37 | 12,863,995.49 | 12,849,672.9 | 16,420,924.93 |
| 应付账款 | 18,329,950.37 | 12,863,995.49 | 12,849,672.9 | 16,420,924.93 |
| 预收款项 | 1,601,209.98 | 1,044,777.7 | 1,851,692.09 | 1,030,081.02 |
| 合同负债 | 1,112,745.3 | 1,283,077.36 | 2,124,603.11 | 1,184,552.54 |
| 应付职工薪酬 | 7,183,542.67 | 7,727,606.11 | 6,888,392.95 | 17,344,484.04 |
| 应交税费 | 10,314,070.9 | 11,237,023.81 | 6,903,197.89 | 10,797,815.03 |
| 其他应付款合计 | 3,190,054.76 | 3,259,718.04 | 3,329,037.64 | 4,607,066.87 |
| 一年内到期的非流动负债 | 677,495.57 | 633,617.83 | 439,778.94 | - |
| 其他流动负债 | 36,401.93 | 39,149.27 | 198,998.41 | 28,979.64 |
| 流动负债合计 | 42,541,319.74 | 38,167,492.64 | 34,649,477.7 | 51,567,203.05 |
| 非流动负债: | | | | |
| 租赁负债 | 8,772,772.11 | 8,699,427.51 | 8,812,076.32 | - |
| 递延收益 | 41,243,305.55 | 42,679,393.25 | 44,112,580.66 | 45,512,734.88 |
| 递延所得税负债 | 276,964.31 | 270,047.64 | 290,381.79 | 297,474.16 |
| 非流动负债合计 | 50,293,041.97 | 51,648,868.4 | 53,215,038.77 | 45,810,209.04 |
| 负债合计 | 92,834,361.71 | 89,816,361.04 | 87,864,516.47 | 97,377,412.09 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 67,631,022 | 67,049,620 | 67,049,620 | 67,049,620 |
| 资本公积 | 501,424,872.58 | 488,391,931 | 485,947,054.33 | 484,691,135.89 |
| 减:库存股 | 2,865,420.07 | 7,894,238.37 | 7,894,238.37 | 7,894,238.37 |
| 其他综合收益 | 1,144,126.67 | 1,170,008.96 | 1,191,609.18 | 1,258,624.68 |
| 盈余公积 | 32,712,914.9 | 32,712,914.9 | 32,712,914.9 | 32,712,914.9 |
| 未分配利润 | 263,875,392.11 | 230,056,141.84 | 240,956,476.29 | 220,241,094.17 |
| 归属于母公司股东权益合计 | 863,922,908.19 | 811,486,378.33 | 819,963,436.33 | 798,059,151.27 |
| 股东权益合计 | 863,922,908.19 | 811,486,378.33 | 819,963,436.33 | 798,059,151.27 |
| 负债和股东权益合计 | 956,757,269.9 | 901,302,739.37 | 907,827,952.8 | 895,436,563.36 |
| 公告日期 | 2026-10-22 | 2026-08-21 | 2026-04-28 | 2026-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |